Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

43

Revenue 2017

Perjeta

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Perjeta was produced by Roche.

NICE rejects Roche's breast cancer drug Perjeta

NICE rejects Roche's breast cancer drug Perjeta Perjeta is used alongside Herceptin or docetaxel to reduce the volume of breast tumours before surgery, making it easier to carry out the operation. ... The preliminary recommendations are open for comment until June 13, and any patient already on

Cancer drugs help Roche beat expectations in first quarter

Cancer drugs help Roche beat expectations in first quarter Co. Among Roche's newer products, breast cancer drug Perjeta (pertuzumab) grew 33% to CHF439m thanks to increased use in combination with Herceptin in HER2-positive breast cancer, while arthritis medication

Roche shares slip as profits miss expectations

Roche shares slip as profits miss expectations and Perjeta (pertuzumab) - which collectively grew 19% to CHF 8.76bn.

Roche's Kadcyla fails in gastric cancer trial

Roche's Kadcyla fails in gastric cancer trial Among its best-performing products were breast cancer therapy Perjeta (pertuzumab), up 66% to CHF 1.04bn in the nine-month period, and this in turn helped boost sales of Herceptin

Roche's Perjeta launches in UK for early breast cancer

Roche's Perjeta launches in UK for early breast cancer Roche's Perjeta is now licensed for use in the UK as a treatment for early-stage breast cancer, a few weeks after the new indication was approved in Europe. ... Perjeta was already approved to treat previously-untreated advanced HER2-positive breast

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

Playing Mind Games
To give a brief strong direction, we need to ascertain how the brand intends to win attention, how it will engage, what its call to action will be and how...
PM Society Digital Award Finalists
P&P are shortlisted for the ‘Craft in Film’ category at this year’s PM Society Digital Awards...
The Exhibition Hall: Past, Present and Future
As I sit here at another pharma conference, I start to reflect on how they have changed over the years....

Infographics